Physician profile
James L Walker
NPI 1134149313
$1,313.42
in general payments reported to CMS, 2019-2025
16 companies · $252 in 2025
The $252 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $254 · 2022: $445 · 2023: $186 · 2024: $177 · 2025: $252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $529.13 | 2021-2025 | Ozempic, Rybelsus |
| Sanofi-Aventis U.S. LLC | $228.87 | 2021-2022 | |
| Abbvie INC. | $183.16 | 2022-2025 | |
| Exact Sciences Corporation | $73.01 | 2023-2024 | Cologuard Collection Kit |
| Lilly USA, LLC | $58.21 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $51.11 | 2025 | Airsupra, Farxiga |
| Otsuka America Pharmaceutical, INC. | $32.00 | 2025 | Rexulti |
| Abbott Laboratories | $21.71 | 2022 | |
| Novartis Pharmaceuticals Corporation | $20.44 | 2023 | |
| Amgen INC. | $19.15 | 2025 | Repatha |
| Glaxosmithkline, LLC. | $19.08 | 2025 | Trelegy Ellipta |
| Xeris Pharmaceuticals, INC. | $16.94 | 2022 | |
| Pfizer INC. | $16.52 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.00 | 2024 | Synjardy, Jardiance |
| Eisai INC. | $14.28 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $13.81 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Walker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.